Vironexis Biotherapeutics Launches with FDA Clearance of IND Application for First-Ever Clinical Trial of an AAV-delivered Cancer Immunotherapy
September 12, 2024 07:00 ET
|
Vironexis Biotherapeutics
Vironexis Biotherapeutics launched today with FDA Clearance of IND application for first-ever clinical trial of an AAV-delivered cancer immunotherapy.